Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Using certain hair products may increase breast cancer risk in black women.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Ozone therapy might improve cancer treatment and reduce its side effects.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.